Ramipril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
===Better Known as: Altace or Ramipro=== | ===Better Known as: Altace or Ramipro=== | ||
* Marketed By: King Pharmaceuticals (Now part of Pfizer Inc.)<br /> | * Marketed By: King Pharmaceuticals (Now part of Pfizer Inc.)<br /> | ||
* Major Indication: Hypertension & Congestive Heart Failure<br /> | * Major Indication: [[Hypertension & Congestive Heart Failure]]<br /> | ||
* Drug Class: [[ACE]] Inhibitor | * Drug Class: [[ACE]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): 1991 (2007)<br /> | * Date of FDA Approval (Patent Expiration): 1991 (2007)<br /> | ||
